WATCH-
Taysha Gene Therapies added to ICE Biotechnology Index 07:04 TSHA Taysha Gene Therapies announced that it has been added to the ICE Biotechnology Index in accordance with the annual reconstitution of the index, effective prior to the U.S. market open on Monday, December 20, 2021. "Taysha's inclusion in this key biotechnology index provides important validation of our platform and value proposition as a company," said RA Session II, President, Founder and CEO of Taysha. "We remain focused on executing our near-term clinical and regulatory milestones, which we believe will continue to increase our visibility within the investment community."
HEYDUDE? Sounds stupid-
Crocs to acquire HEYDUDE for $2.5B 07:02 CROX Crocs announced that it has entered into a definitive agreement to acquire HEYDUDE, a privately-owned casual footwear brand, for $2.5B. The purchase price of $2.5B, subject to customary closing adjustments, will be funded by $2.05B in cash and $450M in Crocs shares issued to Rosano based on the average of the daily volume-weighted average price of our stock for the 20 days immediately prior to the signing date. "We expect to enter into a $2.0 billion Term Loan B Facility and borrow $50 million under the company's existing Senior Revolving Credit Facility to fund the cash consideration." The transaction is expected to close in the first quarter of 2022, subject to customary closing conditions and regulatory approval. Upon completion of the transaction, HEYDUDE will operate as a standalone division. Alessandro Rosano, founder of HEYDUDE, will continue to lead innovative product development as Strategic Advisor and Creative Director. As part of this transaction, Rick Blackshaw was hired to join HEYDUDE as Executive Vice President and Brand President. Blackshaw brings over 25 years of footwear experience and most recently served as the CEO at CCM Hockey and previously held positions as the President of Sperry, President of Keds, and Vice President / General Manager of the Chuck Taylor division of Converse. Blackshaw will be a member of the Crocs Executive Leadership Team and report to CEO Andrew Rees.
Taysha Gene Therapies added to ICE Biotechnology Index 07:04 TSHA Taysha Gene Therapies announced that it has been added to the ICE Biotechnology Index in accordance with the annual reconstitution of the index, effective prior to the U.S. market open on Monday, December 20, 2021. "Taysha's inclusion in this key biotechnology index provides important validation of our platform and value proposition as a company," said RA Session II, President, Founder and CEO of Taysha. "We remain focused on executing our near-term clinical and regulatory milestones, which we believe will continue to increase our visibility within the investment community."
HEYDUDE? Sounds stupid-
Crocs to acquire HEYDUDE for $2.5B 07:02 CROX Crocs announced that it has entered into a definitive agreement to acquire HEYDUDE, a privately-owned casual footwear brand, for $2.5B. The purchase price of $2.5B, subject to customary closing adjustments, will be funded by $2.05B in cash and $450M in Crocs shares issued to Rosano based on the average of the daily volume-weighted average price of our stock for the 20 days immediately prior to the signing date. "We expect to enter into a $2.0 billion Term Loan B Facility and borrow $50 million under the company's existing Senior Revolving Credit Facility to fund the cash consideration." The transaction is expected to close in the first quarter of 2022, subject to customary closing conditions and regulatory approval. Upon completion of the transaction, HEYDUDE will operate as a standalone division. Alessandro Rosano, founder of HEYDUDE, will continue to lead innovative product development as Strategic Advisor and Creative Director. As part of this transaction, Rick Blackshaw was hired to join HEYDUDE as Executive Vice President and Brand President. Blackshaw brings over 25 years of footwear experience and most recently served as the CEO at CCM Hockey and previously held positions as the President of Sperry, President of Keds, and Vice President / General Manager of the Chuck Taylor division of Converse. Blackshaw will be a member of the Crocs Executive Leadership Team and report to CEO Andrew Rees.